BioInvent Announces Nomination of Two New Board Members Ahead of 2026 Annual General Meeting
Kate Hermans: Global life sciences executive with 25+ years of leadership across biopharma, commercial strategy, global operations, and value-creation transformations in both public and venture-backed companiesScott Zinober: Senior investment professio…
Continue Reading